Jane Street Group, LLC X Biotech Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 11,141 shares of XBIT stock, worth $50,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,141

Holding current value

$50,802

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.55 - $7.95 $61,832 - $88,570	11,141 New	11,141 $86,000
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $155,134 - $312,964	38,495 Added 235.78%	54,822 $445,000
Q4 2023 Feb 14, 2024	BUY	$3.56 - $4.65 $58,124 - $75,920	16,327 New	16,327 $65,000
Q2 2023 Aug 14, 2023	BUY	$3.06 - $6.38 $40,413 - $84,260	13,207 New	13,207 $78,000
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $37,371 - $61,381	10,439 New	10,439 $38,000
Q3 2020 Nov 17, 2020	SELL	$13.97 - $21.16 $1.61 Million - $2.44 Million	-115,300 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$10.39 - $16.07 $277,423 - $429,085	-26,701 Reduced 18.8%	115,300 $1.58 Million
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $1.26 Million - $3.54 Million	142,001 New	142,001 $1.51 Million

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

1.13M
Shares

$5.17 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$4.84 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

452K
Shares

$2.06 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

281K
Shares

$1.28 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

254K
Shares

$1.16 Million
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $139M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account